Abstract

This study is a randomized, double-blind, placebo-controlled trial of the trimethoprim sulfamethoxazole (TMP/SMZ) suspension in children with vesicoureteral reflux. The study is designed to recruit 600 children (approximately 300 in each treatment group) and follow them 24 months.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
NIH Inter-Agency Agreements (Y01)
Project #
Y1DK6691-5-0-1
Application #
8316063
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2011
Total Cost
$33,500
Indirect Cost

  Institution

Name
National Institute of Diabetes and Digestive and Kidney Diseases
Department
Type
DUNS #
City
State
Country
Zip Code